Co-treatment of 4d (A2-thio-imidazole derivative), a novel TGR5 agonist, and Sitagliptin (DPP-4 inhibitor) exhibited a GLP-1 secretion and glucose-lowering effect in animal models, while this compound alone exhibits only a slight 1.3-fold increase in GLP-1 secretion [182]
Moiz V, Andreu A, Rodrguez L, Flores L, Ibarzabal A, Lacy A, et al
This is so much more than just a new way to fill a prescription
What are some red flags that I might be using an unapproved GLP-1 agonist
Diabetologia 59 , 14121421 (2016)
Hunter Guevara LR, Beam WBB, Pasternak JJ (2024) To the Brain and Beyond: Neurological Implications of Glucagon-Like Peptide-1 Receptor Agonists